March 2012
Volume 53, Issue 14
ARVO Annual Meeting Abstract  |   March 2012
Prolyl Hydroxylase Inhibition during Hyperoxia Prevents Oxygen-induced Retinopathy in the Rat 50/10 Model
Author Affiliations & Notes
  • George Trichonas
    Ophthalmology, Cleveland Clinic, Cleveland, Ohio
  • George Hoppe
    Ophthalmology, Cleveland Clinic, Cleveland, Ohio
  • Tamara J. Lee
    Ophthalmology, Cleveland Clinic, Cleveland, Ohio
  • Jonathan E. Sears
    Ophthalmology, Cleveland Clinic, Cleveland, Ohio
  • Footnotes
    Commercial Relationships  George Trichonas, None; George Hoppe, None; Tamara J. Lee, None; Jonathan E. Sears, None
  • Footnotes
    Support  Research to Prevent Blindness Challenge Grant, Cleveland Clinic Product Development Fund, Knights Templar Eye Foundation, Clarinda Ross Macular Degeneration Fund.
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 2534. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      George Trichonas, George Hoppe, Tamara J. Lee, Jonathan E. Sears; Prolyl Hydroxylase Inhibition during Hyperoxia Prevents Oxygen-induced Retinopathy in the Rat 50/10 Model. Invest. Ophthalmol. Vis. Sci. 2012;53(14):2534.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To study the effect of systemic prolyl hydroxylase inhibition (PHDi) in the rat oxygen-induced retinopathy (OIR) model.

Methods: : Litters of Sprague-Dawley rat pups and their mothers were transferred within 10 h after birth to oxygen exposure chambers (BioSpherix) where they were subjected to alternating 24-h periods of 50% oxygen and 10% oxygen for 14 days. Control rats were raised simultaneously in room air. On postnatal day (P) 14, the oxygen-exposed rats were returned to room air. OIR animals received intraperitoneal injections of dimethyloxalylglycine (DMOG, 200μg/g), an antagonist of α-ketoglutarate cofactor and inhibitor for PHD, on P3, P5, P7 and P9. Control animals received intraperitoneal injections of PBS. On P14 and P21, animals were anesthetized with Ketamine (80 mg/kg) and Xylazine (8 mg/kg) and were perfused through the left ventricle with 0.5 ml of 0.1% Evans Blue dye. Eye cups were dissected to prepare retinal flat-mounts which were examined under fluorescent microscopy. Neovascularization and avascular areas were assessed on retinal flat-mounts by computerized image analysis.

Results: : Alternating hyperoxia/hypoxia in untreated rats led to peripheral as well as central vascular obliteration on day P14. Rats that were treated with systemic DMOG by intraperitoneal injections had less posterior ischemia and greater peripheral vascularity than control animals treated with PBS injections. DMOG administration had no adverse effect on retinal vasculature of rats reared in room air.

Conclusions: : We have previously demonstrated that PHDi prevents OIR in mice exposed to 5 days of 75% oxygen followed by 5 days of 21% oxygen. The 50/10 rat experiments demonstrate that PHDi is also effective in a 24-h alternating hyperoxia/hypoxia model. The rat OIR model further validates the therapeutic value of PHDi to prevent retinopathy of prematurity, because it reduces oxygen-induced vascular obliteration and retinovascular growth attenuation in prolonged and/or alternating hyperoxia.

Keywords: retinopathy of prematurity • hypoxia • retinal neovascularization 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.